Arrowstreet Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,945
| Closed | -$495K | – | 1320 |
|
|
2022
Q2 | $495K | Buy |
+15,945
| New | +$495K | ﹤0.01% | 1070 |
|
|
2019
Q1 | – | Sell |
-81,093
| Closed | -$4.81M | – | 1765 |
|
|
2018
Q4 | $4.81M | Buy |
81,093
+26,293
| +48% | +$1.56M | 0.01% | 585 |
|
|
2018
Q3 | $3.61M | Buy |
54,800
+27,608
| +102% | +$1.82M | 0.01% | 571 |
|
|
2018
Q2 | $1.37M | Sell |
27,192
-29,569
| -52% | -$1.49M | ﹤0.01% | 752 |
|
|
2018
Q1 | $2.99M | Buy |
+56,761
| New | +$2.99M | 0.01% | 672 |
|
|
2017
Q2 | – | Sell |
-290,266
| Closed | -$8.43M | – | 1129 |
|
|
2017
Q1 | $8.43M | Buy |
+290,266
| New | +$8.43M | 0.03% | 433 |
|
|
2016
Q4 | – | Sell |
-738,884
| Closed | -$23.3M | – | 1861 |
|
|
2016
Q3 | $23.3M | Buy |
738,884
+205,144
| +38% | +$6.47M | 0.08% | 256 |
|
|
2016
Q2 | $15M | Buy |
533,740
+223,380
| +72% | +$6.28M | 0.05% | 336 |
|
|
2016
Q1 | $11.3M | Sell |
310,360
-54,101
| -15% | -$1.97M | 0.05% | 340 |
|
|
2015
Q4 | $14.6M | Sell |
364,461
-16,562
| -4% | -$663K | 0.07% | 276 |
|
|
2015
Q3 | $10.9M | Buy |
381,023
+36,331
| +11% | +$1.04M | 0.05% | 322 |
|
|
2015
Q2 | $11.4M | Buy |
344,692
+112,638
| +49% | +$3.71M | 0.06% | 245 |
|
|
2015
Q1 | $6.67M | Sell |
232,054
-23,031
| -9% | -$662K | 0.04% | 355 |
|
|
2014
Q4 | $6.95M | Buy |
255,085
+69,999
| +38% | +$1.91M | 0.04% | 379 |
|
|
2014
Q3 | $3.94M | Buy |
185,086
+55,248
| +43% | +$1.18M | 0.02% | 444 |
|
|
2014
Q2 | $2.92M | Sell |
129,838
-3,951
| -3% | -$88.7K | 0.02% | 519 |
|
|
2014
Q1 | $3.38M | Buy |
133,789
+73,040
| +120% | +$1.85M | 0.02% | 524 |
|
|
2013
Q4 | $1.4M | Buy |
+60,749
| New | +$1.4M | 0.01% | 755 |
|